H.C. Wainwright raises Enliven Therapeutics target price to $73 from $65
ELVN•H.C. Wainwright raised its target price for Enliven Therapeutics to $73 from $65.
Related News
Russian oil exports by Arctic route jump as freight rates soar, data shows
USO•
Vermilion Energy Inc.: Scotiabank raises target price to C$20.00 from C$17.00
VET•
Zymeworks appoints Suzanne Monahan as senior vice president, commercial and general manager, Theravance Biopharma
ZYME•
Stifel cuts Zurn Elkay Water Solutions target price to $56 from $62
ZWS•
Lam Research target price raised to $375 from $320
LRCX•